BTTA

General

Type : Triazol

Chemical_Nomenclature : N-[[1-[2-[2-(2-hexoxyethoxy)ethoxy]ethyl]-1,2,3-triazol-4-yl]methyl]-1-(1H-1,2,3-triazol-4-yl)-N-(2H-1,2,3-triazol-4-ylmethyl)methanamine

Canonical SMILES : CCCCCCOCCOCCOCC[N]1C=C(N=N1)CN(CC2=C[N]([H])N=N2)CC3=N[N](N=C3)[H]

InChI : InChI=1S\/C21H36N10O3\/c1-2-3-4-5-7-32-9-11-34-12-10-33-8-6-31-18-21(26-29-31)17-30(15-19-13-22-27-24-19)16-20-14-23-28-25-20\/h13-14,18H,2-12,15-17H2,1H3,(H,22,24,27)(H,23,25,28)

InChIKey : TULQAAWRGBJEDU-UHFFFAOYSA-N

Other name(s) : TN9


MW : 476.58

Formula : C21H36N10O3

CAS_number :

PubChem :

UniChem : TULQAAWRGBJEDU-UHFFFAOYSA-N

Target

Families : BTTA ligand of proteins in family
Haloalkane_dehalogenase-HLD2

Structure :
8J1O

Protein :
rhoso-halo1

References

No reference